November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Clinical Trial Evaluates VasoClip Versus WeckClip in Robotic Urologic Procedures

❤️ Conditions & Care 2 min read 👁 11

A recent phase III noninferiority trial compared the efficacy and early safety of the VasoClip polymer device with the established WeckClip during robotic urologic surgeries.

❤️Conditions & Care

Key points

  • Phase III noninferiority trial compared VasoClip and WeckClip in robotic urologic surgery.
  • The study analyzed 573 applied clips across 40 patients over a two-week follow-up period.
  • Overall success rates were 96.0% for VasoClip and 92.4% for WeckClip, meeting the noninferiority margin.

A prospective, randomized phase III noninferiority trial published in Nature Health Sciences has evaluated the performance of VasoClip, a polymer ligating clip featuring a Z-groove and elastic notch, against the conventional WeckClip during robotic urologic surgeries. Conducted by researchers from institutions including Chung-Ang University Gwangmyeong Hospital and The Catholic University of Korea, the study sought to determine if the newer device performed comparably to standard instruments used for vessel and tissue ligation.

The investigation involved 40 patients undergoing robotic urologic procedures who were randomly assigned in a 1:1 ratio to receive either VasoClip or WeckClip, resulting in a total of 573 applied clips. Overall ligation success reached 96.0% for the VasoClip group compared to 92.4% for the WeckClip group, yielding a clustering-adjusted absolute risk difference of 3.6%. While this outcome met the predetermined noninferiority criterion, the authors emphasize that the findings should be interpreted with caution due to the small sample size and because the initial sample-size calculation did not account for within-patient clustering.

During a two-week follow-up period, no severe complications of Clavien-Dindo grade III or higher were observed, and researchers reported no early device-related safety signals. Although exploratory subgroup analysis suggested numerically higher success rates for VasoClip in body-structure applications, the difference lacked statistical significance. Readers should consult a qualified physician for personalized medical advice regarding surgical procedures and treatment options.

What to know: A clinical study comparing VasoClip and WeckClip in 40 patients found similar early efficacy and safety outcomes in robotic urologic surgery, though larger trials are needed to confirm these findings.

Source Nature Health Sciences — nature.com/articles/s41598-026-79203-9 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.